Developing model language for disclosing financial interests to potential clinical research participants.
作者信息
Weinfurt Kevin P, Allsbrook Jennifer S, Friedman Joëlle Y, Dinan Michaela A, Hall Mark A, Schulman Kevin A, Sugarman Jeremy
机构信息
Duke University School of Medicine, Durham, NC, USA.
出版信息
IRB. 2007 Jan-Feb;29(1):1-5.
Abstract
摘要
相似文献
1
2
Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators.披露临床研究中的利益冲突：机构审查委员会、利益冲突委员会及研究者的观点
J Law Med Ethics. 2006 Fall;34(3):581-91, 481. doi: 10.1111/j.1748-720x.2006.00072.x.
3
The limits of disclosure: what research subjects want to know about investigator financial interests.披露的限度：研究对象想了解的关于研究者经济利益的情况。
J Law Med Ethics. 2006 Fall;34(3):592-9, 481. doi: 10.1111/j.1748-720x.2006.00073.x.
4
Disclosure of financial relationships to participants in clinical research.向临床研究参与者披露财务关系。
N Engl J Med. 2009 Aug 27;361(9):916-21. doi: 10.1056/NEJMsb0902598.
5
Currents in contemporary ethics: ethical and practical concerns in developing payment policies for research involving children and adolescents.
J Law Med Ethics. 2008 Summer;36(2):413-8. doi: 10.1111/j.1748-720X.2008.00285.x.
6
Expanding disclosure of conflicts of interest: the views of stakeholders.扩大利益冲突的披露范围：利益相关者的观点。
IRB. 2003 Jan-Feb;25(1):1-8.
7
Disclosing conflicts of interest to research subjects: an ethical and legal analysis.向研究对象披露利益冲突：伦理与法律分析
Account Res. 2004 Apr-Jun;11(2):141-59. doi: 10.1080/03050620490512322.
8
Conflicts of interest in research: how IRBs address their own conflicts.研究中的利益冲突：机构审查委员会如何处理自身的冲突。
IRB. 2007 Jan-Feb;29(1):6-12.
9
Putting the "ethics" into "research ethics".将“伦理”融入“研究伦理”。
Am J Bioeth. 2005 Winter;5(1):51-3; author reply W15-8. doi: 10.1080/15265160590927822.
10
Developing countries need effective ethics review committees.发展中国家需要有效的伦理审查委员会。
Lancet. 2003 Aug 23;362(9384):627. doi: 10.1016/S0140-6736(03)14203-1.
引用本文的文献
1
Using Cognitive Interviews to Enhance Measurement in Empirical Bioethics: Developing a Measure of the Preventive Misconception in Biomedical HIV Prevention Trials.运用认知访谈提升实证生物伦理学中的测量：开发一项关于生物医学HIV预防试验中预防性误解的测量指标。
AJOB Empir Bioeth. 2016;7(1):17-23. doi: 10.1080/23294515.2015.1037967. Epub 2015 May 1.
2
Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research.患者对心脏病学研究中知情同意书的保密性、责任和财务方面的反应。
Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):151-8. doi: 10.1161/CIRCOUTCOMES.109.849273. Epub 2010 Jan 12.
3
Effects of disclosing financial interests on participation in medical research: a randomized vignette trial.披露经济利益对参与医学研究的影响：一项随机 vignette 试验
Am Heart J. 2008 Oct;156(4):689-97. doi: 10.1016/j.ahj.2008.06.001.
4
Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents.生物医学文献中财务利益披露的一致性：以冠状动脉支架为例。
PLoS One. 2008 May 7;3(5):e2128. doi: 10.1371/journal.pone.0002128.
5
Effects of disclosing financial interests on attitudes toward clinical research.披露经济利益对临床研究态度的影响。
J Gen Intern Med. 2008 Jun;23(6):860-6. doi: 10.1007/s11606-008-0590-4. Epub 2008 Apr 2.
本文引用的文献
1
Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure.潜在研究参与者对经济利益冲突的看法：有效披露的障碍与机遇
J Gen Intern Med. 2006 Sep;21(9):901-6. doi: 10.1111/j.1525-1497.2006.00502.x.
2
Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants.学术医疗中心向潜在研究参与者披露经济利益冲突的政策。
Acad Med. 2006 Feb;81(2):113-8. doi: 10.1097/00001888-200602000-00003.
3
Institutional academic industry relationship: results of interviews with university leaders.机构的学术与行业关系：对大学领导的访谈结果
Account Res. 2004 Apr-Jun;11(2):103-18. doi: 10.1080/03050620490512296.
4
Potential research participants' views regarding researcher and institutional financial conflicts of interest.潜在研究参与者对研究者和机构财务利益冲突的看法。
J Med Ethics. 2004 Feb;30(1):73-9. doi: 10.1136/jme.2002.001461.
5
6
7
Scope and impact of financial conflicts of interest in biomedical research: a systematic review.生物医学研究中经济利益冲突的范围与影响：一项系统综述
JAMA. 2003;289(4):454-65. doi: 10.1001/jama.289.4.454.
8
Protecting research subjects--what must be done.保护研究对象——必须采取的措施。
N Engl J Med. 2000 Sep 14;343(11):808-10. doi: 10.1056/NEJM200009143431112.
9
Uneasy alliance--clinical investigators and the pharmaceutical industry.不安的联盟——临床研究人员与制药行业
N Engl J Med. 2000 May 18;342(20):1539-44. doi: 10.1056/NEJM200005183422024.
10
Is academic medicine for sale?学术医学可以买卖吗？
N Engl J Med. 2000 May 18;342(20):1516-8. doi: 10.1056/NEJM200005183422009.
Zotero 插件